These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9219602)

  • 1. Losartan does not influence the blood platelet aggregation in normotensive rats.
    Chabielska E; Pawlak R; Buczko W
    Acta Physiol Hung; 1996; 84(3):271-2. PubMed ID: 9219602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
    Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
    Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drugs affecting the renin-angiotensin system on venous thrombosis in normotensive rats.
    Chabielska E; Pawlak R; Buczko W
    Pol J Pharmacol; 1996; 48(1):89-91. PubMed ID: 9112634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of losartan on short-term variability of blood pressure of renovascular hypertensive rats: a spectral study.
    Ponchon P; Grichois ML; Elghozi JL
    J Hypertens Suppl; 1993 Dec; 11(5):S244-5. PubMed ID: 8158366
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronic treatment with losartan on blood pressure, endothelin-like immunoreactivity and nitric oxide in normotensive rats.
    Sacerdote A; Cosenzi A; Bocin E; Molino R; Seculin P; Plazzotta N; Luxich E; Bellini G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1670-3. PubMed ID: 8903630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B; Brunner HR
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 10. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
    Smith JR; Wahhab A; Moore D; Ganter RC; Moore GJ
    Drug Des Discov; 1994 Nov; 12(2):113-9. PubMed ID: 9116166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 12. Losartan (Cozaar).
    Baldinger S
    Conn Med; 1996 May; 60(5):281-4. PubMed ID: 8998906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How well have animal studies with losartan predicted responses in humans?
    Sweet CS; Nelson EB
    J Hypertens Suppl; 1993 Apr; 11(3):S63-7. PubMed ID: 8315522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro.
    Pawlikowski M; Kunert-Radek J
    Biochem Biophys Res Commun; 1997 Mar; 232(2):292-3. PubMed ID: 9125166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new antihypertensive class: the angiotensin receptor antagonist.
    Kupecz D
    Nurse Pract; 1996 Mar; 21(3):106, 109, 113-4. PubMed ID: 8710244
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition.
    Chłopicki S; Koda M; Chabielska E; Buczko W; Gryglewski RJ
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):715-22. PubMed ID: 11192944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
    Ibsen H; Rasmussen S; Slatanach R
    Ugeskr Laeger; 1996 Jun; 158(26):3798-802. PubMed ID: 8686080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.